Date	Period	Revenue/Estimate	Earnings Call
May 12, 2023	2023/Q1	35.000M / --	--
Nov 4, 2022	2022/Q3	358.000M / --	--
May 13, 2022	2022/Q1	193.000M / --	--
Nov 5, 2021	2021/Q3	125.000M / --	--
May 7, 2021	2021/Q1	62.000M / --	--

DatePeriodRevenue/EstimateEarnings Call

May 12, 20232023/Q135.000M / ----

Nov 4, 20222022/Q3358.000M / ----

May 13, 20222022/Q1193.000M / ----

Nov 5, 20212021/Q3125.000M / ----

May 7, 20212021/Q162.000M / ----

Unlock Free Earnings Estimates

Open Account

Oncolys BioPharma: Earnings Conference materials

Feb 9 18:00 ET

Oncolys BioPharma: Summary of financial results for the fiscal year ending 2024/12 [Japanese GAAP] (unconsolidated)

Feb 7 01:00 ET

Oncolys BioPharma: Notice regarding differences between full-year results and previous fiscal year results

Feb 7 01:00 ET

Oncolys BioPharma: Summary of financial results for the 3rd quarter of the fiscal year ending 2024/12 [Japanese GAAP] (unconsolidated)

Nov 7, 2024 23:00 ET

Symbol Price % Chg

See the daily top gainer.